Research At Alivation
Dr. Walt Duffy, Founder and Medical Director of Alivation Research, has been the principal investigator on over 150 clinical trials since 2005. Alivation could not have done it without the participation of the general public. Take a look at our current studies to see if you are eligible to participate.
Who Are We?
Alivation Research takes part in research studies that help further science and medicine, and we are looking for qualified candidates to help. Our goal is to measure results and to determine the safety and tolerability of treatment options. Research makes it possible for our patients to access the newest treatments when traditional treatments may not be working. Participants are often compensated for their time and travel and receive their study medication and devices at no cost.
What do you get out of it?
Compensation from our research sponsors.
Some healthcare (study medication)
A feeling that you have participated in something meaningful.
A chance to help science, yourself, & others
What Studies Do We Currently Offer?
We offer both adult and pediatric study trials. They each have their own distinct requirements. Be sure to read the description carefully. Then complete the form below to contact us and receive more information about joining a study.
Study Number #1 Indication: Early Alzheimer's Disease Investigational Product: Sildenafil Age: 55 to 90 Compensation: $975 (max)
Study Number #2 Indication: ADHD Investigational Product: Game-Based Digital Therapy Age: 22 to 55 Compensation: $175 (max)
Study Number #3 Indication: Major Depressive Order Investigational Product: ALTO-100 (benzylpiperazine amiopyridine phosphate) Age: 19 to 65 Compensation: $615 (max)
Study Number #4 Indication: Treatment Resistant Depression Investigational Product: Comp 360 (synthetic psilocybin) Age: 19 or older Compensation: $1,300 (max)
Study Number #5 Indication: Obstructive Sleep Apnea Investigational Product: Hypoglossal Nerve Stimulator Age: 22 or older Compensation: $975 (max)
Study Number #6 Indication: Meningococcal Disease Investigational Product: Meningitis Vaccine Age: 18 to 25 Compensation: $2,455 (max)
Study Number #7 Indication: Treatment Resistant Depression Investigational Product: Liafensine Age: 19 to 70 Compensation: $800 (max)
Study Number #8 Indication: Tardive Dyskinesia Investigational Product: Valbenazine Age: 19 or older Compensation: $100 per visit
Study Number #9 Indication: Subacute Suicidal Behavior Investigational Product: NRX to Lurasidone Age: 19 to 65 Compensation: $625 (max)
Study Number #10 Indication: Meningococcal Disease Investigational Product: Meningitis Vaccine Age: 10 to 17 Compensation: $2940 (max)
Study Number #11 Indication: Tourette's Disorder Investigational Product: Ecopipam Age: 6 to 18 Compensation: $75 per visit
Study Number #12 Indication: ADHD Investigational Product: Centanafadine Age: 4 to 17 Compensation: $53 per visit
Study Number #13 Indication: ADHD Investigational Product: Azstary Age: 4 to 12 Compensation: $300 (max)
Want to Join a Study?
If you think that you fit any of the requirements for our research studies fill out this form below, which will then be sent to us for review. If you qualify for the research study, we will have a member of our team get back to you on the next steps. To expedite the process, please print the ROI Form and have your healthcare professional complete it.
If you are looking to work with Alivation Research. Please fill out and submit this form.